CY2299B1 - Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and dema - Google Patents

Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and dema

Info

Publication number
CY2299B1
CY2299B1 CY0200058A CY0200058A CY2299B1 CY 2299 B1 CY2299 B1 CY 2299B1 CY 0200058 A CY0200058 A CY 0200058A CY 0200058 A CY0200058 A CY 0200058A CY 2299 B1 CY2299 B1 CY 2299B1
Authority
CY
Cyprus
Prior art keywords
dichlorophenyl
diamino
triazine
dema
pain
Prior art date
Application number
CY0200058A
Other languages
English (en)
Inventor
Meire Nakamura-Craig
Michael John Leach
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CY2299B1 publication Critical patent/CY2299B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY0200058A 1992-02-19 2002-10-14 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and dema CY2299B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929203483A GB9203483D0 (en) 1992-02-19 1992-02-19 Anti-inflammatory compounds

Publications (1)

Publication Number Publication Date
CY2299B1 true CY2299B1 (en) 2003-07-04

Family

ID=10710643

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0200058A CY2299B1 (en) 1992-02-19 2002-10-14 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and dema

Country Status (18)

Country Link
US (1) US5712277A (xx)
EP (1) EP0626851B1 (xx)
KR (1) KR950700067A (xx)
AT (1) ATE204476T1 (xx)
AU (1) AU684711B2 (xx)
CA (1) CA2129043C (xx)
CY (1) CY2299B1 (xx)
DE (1) DE69330638T2 (xx)
DK (1) DK0626851T3 (xx)
ES (1) ES2162813T3 (xx)
GB (2) GB9203483D0 (xx)
GR (1) GR3036958T3 (xx)
IL (1) IL104775A (xx)
MX (1) MX9300927A (xx)
NZ (1) NZ249197A (xx)
PT (1) PT626851E (xx)
TW (1) TW226331B (xx)
WO (1) WO1993016700A1 (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9424766D0 (en) * 1994-12-07 1995-02-08 Wellcome Found Pharmaceutical composition
RU2145602C1 (ru) * 1994-12-30 2000-02-20 Де Вэллкам Фаундейшн Лимитед Способы получения ламотриджина, промежуточные соединения и способ получения фармацевтической композиции
GB9625795D0 (en) * 1996-12-12 1997-01-29 Smithkline Beecham Plc Novel treatment
GB9726987D0 (en) 1997-12-22 1998-02-18 Glaxo Group Ltd Compounds
ATE303162T1 (de) * 1999-04-09 2005-09-15 Euro Celtique Sa Natrium kanalblocker zusammensetzungen und deren verwendung
ES2253579T3 (es) 2001-09-03 2006-06-01 Newron Pharmaceuticals S.P.A. Composicion farmaceutica que comprende gabapentina o un analogo suyo y una alfa-aminoamida y su uso analgesico.
JP5319920B2 (ja) * 2004-09-10 2013-10-16 ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー ナトリウムおよび／またはカルシウムチャンネル選択的調節因子として活性のある医薬の製造のための（ハロベンジルオキシ）ベンジルアミノ−プロパンアミドの使用
US10576086B2 (en) * 2015-06-12 2020-03-03 University Of Greenwich Triazine derivatives as interferon-gamma inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637688A (en) * 1970-01-09 1972-01-25 American Home Prod 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines
US4310551A (en) * 1979-03-19 1982-01-12 Diamond Shamrock Corporation Pharmacologically active substituted 1,2,4-triazines
AU530999B2 (en) * 1979-06-01 1983-08-04 Wellcome Foundation Limited, The Substituted amino triazines and their use in treatment of cns disorders
GB8613183D0 (en) * 1986-05-30 1986-07-02 Wellcome Found Triazine salt
GB9012312D0 (en) * 1990-06-01 1990-07-18 Wellcome Found Pharmacologically active cns compounds

Also Published As

Publication number Publication date
GB9414348D0 (en) 1994-09-07
TW226331B (xx) 1994-07-11
IL104775A0 (en) 1993-06-10
PT626851E (pt) 2002-02-28
WO1993016700A1 (en) 1993-09-02
GB2277265A (en) 1994-10-26
CA2129043C (en) 2004-01-27
DE69330638T2 (de) 2002-06-27
US5712277A (en) 1998-01-27
IL104775A (en) 1997-02-18
NZ249197A (en) 1997-05-26
ATE204476T1 (de) 2001-09-15
CA2129043A1 (en) 1993-09-02
GB2277265B (en) 1996-01-10
MX9300927A (es) 1994-08-31
KR950700067A (ko) 1995-01-16
EP0626851B1 (en) 2001-08-22
GB9203483D0 (en) 1992-04-08
ES2162813T3 (es) 2002-01-16
AU3509293A (en) 1993-09-13
DK0626851T3 (da) 2001-12-03
JPH07503968A (ja) 1995-04-27
DE69330638D1 (de) 2001-09-27
GR3036958T3 (en) 2002-01-31
EP0626851A1 (en) 1994-12-07
JP3713271B2 (ja) 2005-11-09
AU684711B2 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
CA2213339A1 (en) Method of treating adenosine depletion
GB2206788B (en) 5 ht-3 antagonist for the treatment or reduction of dependence
ZA941530B (en) Use of lamotrigine in the treatment of neuro-AIDS
GB9407305D0 (en) Pharmaceutical compositions
IL98258A0 (en) Composition for treating impotence containing doxazosin,amlodipine,or u.k.52,046
ZA95679B (en) Products containing G-CSF and TNF binding protein
CA2281807A1 (en) Method of treating a tumor
GR3036958T3 (en) Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and dema.
DK0583026T3 (xx)
CA2285477A1 (en) Formulations and methods to treat and prevent equine protozoal myeloencephalitis
WO1998025594A3 (en) Lamotrigine in the treatment and prophylaxis of migraine
MD1051C2 (ro) Remediu antiherpetic
GB2282326A (en) Use of 3,5-diamino-6-(2,3 dichlorophenyl)-1,2,4-triazine isethionate for the treatment and prevention of dependence,tolerance and sensitization of drugs
IL101630A0 (en) Use of 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds for the treatment of aids
ZA929143B (en) Agents for use in the prophylaxis and therapy of fungal infections.